HeartPhone Cancer Survivors Trial 2019

• Status: Terminated
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a behavioral study that will examine changes in physical activity and vascular health in response to a digital tool (app) that will appear on participant's lock screen of their Android phone. Participants will be asked to use this app for 3 months and to wear a Fitbit device continuously throughout the study. Participants will be asked to complete questionnaires, participate in fitness testing and measures of cardiovascular health at 3 months and 6 months after baseline assessments. The hypothesis is that exposure to the app will lead to increased physical activity volume and improved microvessel function.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Penn State University
• Treatments: Acetylcholine; Nitroprusside

Criteria

Inclusion Criteria:

• Age 18-65 years

• Diagnosis of breast cancer, leukemia, or lymphoma <15 yrs

• Completed chemotherapy with cardiotoxic anthracycline-based agents 1+ year ago

• English-proficiency

• Own & use smartphone with Android operating system

Main Study and Ancillary Study Exclusion Criteria:

• Currently receiving curative treatment for cancer

• 90+ min/week moderate (or greater) intensity PA

• Any medical contraindications on the Physical Activity Readiness Questionnaire

• Require an assistive device for mobility or has any other condition that may limit or prevent participation in moderate-intensity physical activity

• Current smoker

• Pregnant or planning to become pregnant in the next 6 mos/breastfeeding

• Allergy to test substances

• Allergy to latex

Ancillary Study:

• Taking metformin

• Current medications that could conceivably alter the cardiovascular or thermoregulatory control or responses (e.g. beta blockers, calcium channel blockers, angiotensin receptor blockers)